Jin Zeng

Translational Chinese Medicine Key Laboratory Of Sichuan, Sichuan Chongqing Joint Key Laboratory Of Innovation Of New Drugs Of Traditional Chinese Medicine
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Integrating network pharmacology and metabolomics to explore the mechanism of Xihuang Pill in exerting anti-tumor immune effects against pancreatic ductal adenocarcinoma.

Integrating network pharmacology and metabolomics to explore the mechanism of Xihuang Pill in exerting anti-tumor immune effects against pancreatic ductal adenocarcinoma.

Journal: Journal of ethnopharmacology

Published: August 12, 2025

Regulating Intratumoral Fungi With Hydrogels: A Novel Approach to Modulating the Tumor Microbiome for Cancer Therapy.

Regulating Intratumoral Fungi With Hydrogels: A Novel Approach to Modulating the Tumor Microbiome for Cancer Therapy.

Journal: Cancer medicine

Published: January 17, 2025

Construction and development prospect of evaluation indicator system for sustainable utilization of traditional Chinese medicine resources based on DPSIR model

Construction and development prospect of evaluation indicator system for sustainable utilization of traditional Chinese medicine resources based on DPSIR model

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: January 13, 2025

Current landscape of innovative drug development and regulatory support in China.

Current landscape of innovative drug development and regulatory support in China.

Journal: Signal transduction and targeted therapy

Published: September 26, 2024

The role of tetrahydrocurcumin in disease prevention and treatment.

The role of tetrahydrocurcumin in disease prevention and treatment.

Journal: Food & function

Published: June 05, 2024

New drug discovery and prospect of small nucleic acids derived from traditional Chinese medicine and natural medicine

New drug discovery and prospect of small nucleic acids derived from traditional Chinese medicine and natural medicine

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: May 30, 2024

Rutaecarpine Attenuates Monosodium Urate Crystal-Induced Gouty Inflammation via Inhibition of TNFR-MAPK/NF-κB and NLRP3 Inflammasome Signaling Pathways.

Rutaecarpine Attenuates Monosodium Urate Crystal-Induced Gouty Inflammation via Inhibition of TNFR-MAPK/NF-κB and NLRP3 Inflammasome Signaling Pathways.

Journal: Chinese journal of integrative medicine

Published: May 26, 2024

Glucuronidation dynamics of curcumin and tetrahydrocurcumin for differential structures and chemical reactivities in human liver microsome and uridine diphosphate glucuronosyltransferase 2B7.

Glucuronidation dynamics of curcumin and tetrahydrocurcumin for differential structures and chemical reactivities in human liver microsome and uridine diphosphate glucuronosyltransferase 2B7.

Journal: Food chemistry

Published: September 14, 2023

Kinsenoside from Anoectochilus roxburghii (Wall.) Lindl. suppressed oxidative stress to attenuate aging-related learning and memory impairment via ERK/Nrf2 pathway.

Kinsenoside from Anoectochilus roxburghii (Wall.) Lindl. suppressed oxidative stress to attenuate aging-related learning and memory impairment via ERK/Nrf2 pathway.

Journal: Journal of ethnopharmacology

Published: August 12, 2023

LC-MS-based metabolomics reveals the mechanism of anti-gouty arthritis effect of Wuwei Shexiang pill.

LC-MS-based metabolomics reveals the mechanism of anti-gouty arthritis effect of Wuwei Shexiang pill.

Journal: Frontiers in pharmacology

Published: April 28, 2023

Xiaoxuming decoction cutting formula reduces LPS-stimulated inflammation in BV-2 cells by regulating miR-9-5p in microglia exosomes.

Xiaoxuming decoction cutting formula reduces LPS-stimulated inflammation in BV-2 cells by regulating miR-9-5p in microglia exosomes.

Journal: Frontiers in pharmacology

Published: March 10, 2023

Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer.

Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer.

Journal: Frontiers in pharmacology

Published: February 13, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026